EMEA-000971-PIP01-10-M03

Key facts

Invented name
Coagadex
Active substance
Human coagulation factor X
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0389/2017
PIP number
EMEA-000971-PIP01-10-M03
Pharmaceutical form(s)
Powder for solution for injection or infusion
Condition(s) / indication(s)
Treatment of hereditary factor X deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Bio Products Laboratory Limited
Tel. +44 2089572200
E-mail: medinfo@bpl.co.uk
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000971-PIP01-10-M03
Compliance opinion date
26/01/2018
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating